pancreatic cancer
Conditions
Interventions
2:Operation+HIPEC
Sponsors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Men and women aged 18 to 75 with confirmed pancreatic cancer; (2) No lymph node involvement or lymph node involvement can be resected; (3) No distant metastasis except peritoneum (M0);(4) EGCO score 1,500 / mm3, platelet >150,000/ L, creatinine clearance > 60 mL/min according to Cockcroft formula); (6) No CRS+HIPEC treatment was performed before entering the experiment; (7) Informed consent of the patient and his/her family.
Exclusion criteria
Exclusion criteria: 1. Extraperitoneal metastasis (M1); 2. Pancreatococcygeal combined splenectomy; 3. High degree of tumor differentiation and histological characteristics of signet-ring cells; 4. The tumor or metastatic lymph nodes cannot be resected; 5. Coexisting with another malignant tumor disease; 6. Severe liver, kidney and cardiovascular dysfunction; 7. Unable to tolerate HIPEC treatment; 8. Chemotherapy was performed before the experiment; 9. Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to relapse;Distant metastasis;Disease-free survival;Overall survival;Survival rates; | — |
Countries
China
Contacts
Public ContactHeshui Wu
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed